TY - JOUR
T1 - NEMHESYS-European Perspective on the Implementation of Next-generation Sequencing Into Clinical Diagnostics
AU - Serramito-Gómez, Inmaculada
AU - Clarke, Kathryn M
AU - Rodríguez-Vicente, Ana Eugenia
AU - McGimpsey, Julie E
AU - Abáigar, María
AU - Díez, Carlos Barranquero
AU - Benito, Rocío
AU - Bullinger, Lars
AU - Mills, Ken I
AU - Hernández Rivas, Jesús María
PY - 2021/3
Y1 - 2021/3
N2 - NGS Establishment in Multidisciplinary Healthcare (NEMHESYS) is an Erasmus+ programme with the purpose of providing qualified staff with the essential technical and bioinformatic knowledge and skills on next-generation sequencing (NGS) to be able to carryout NGS studies and perform some of the most common types of analyses. The clinical application of NGS has become easier with advancements in technologies. However, the investment needed to bring NGS into medical practice remains significant, with the scale of knowledge required being unprecedented at most hospitals. In addition, these novel technologies bring new challenges in translating NGS to clinical practice, at both technical and regulatory level, in terms of data management, interpretation of the results, and genetic counseling. All these aspects justify the consideration of what will be the precise role of NGS in diagnosis, risk assessment, response prediction, and treatment monitoring, today and tomorrow. Thus, to evaluate the implementation of NGS in European healthcare/research centers, a mapping survey was carried out, based on previous NGS mapping studies
AB - NGS Establishment in Multidisciplinary Healthcare (NEMHESYS) is an Erasmus+ programme with the purpose of providing qualified staff with the essential technical and bioinformatic knowledge and skills on next-generation sequencing (NGS) to be able to carryout NGS studies and perform some of the most common types of analyses. The clinical application of NGS has become easier with advancements in technologies. However, the investment needed to bring NGS into medical practice remains significant, with the scale of knowledge required being unprecedented at most hospitals. In addition, these novel technologies bring new challenges in translating NGS to clinical practice, at both technical and regulatory level, in terms of data management, interpretation of the results, and genetic counseling. All these aspects justify the consideration of what will be the precise role of NGS in diagnosis, risk assessment, response prediction, and treatment monitoring, today and tomorrow. Thus, to evaluate the implementation of NGS in European healthcare/research centers, a mapping survey was carried out, based on previous NGS mapping studies
U2 - 10.1097/HS9.0000000000000541
DO - 10.1097/HS9.0000000000000541
M3 - Article
C2 - 33623883
SN - 2572-9241
VL - 5
JO - HemaSphere
JF - HemaSphere
IS - 3
M1 - e541
ER -